Close Menu

Locus Biosciences is trying to combat so-called superbugs — bacteria that are resistant to many antibiotics — by engineering the bacteriophages that naturally infect them, NPR reports.

The firm, it says, is using CRISPR to develop a mix of three phages to target particular bacterial genes, that way the treatment only targets particular bacteria.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.